China Fines Cos. $1M Over Drug Ingredient Monopoly
Chinese authorities on Monday fined two drug companies more than $1 million for trying to control the market for a fundamental ingredient used in blood pressure medication....To view the full article, register now.
Already a subscriber? Click here to view full article